Anne and Franc, who are living with type 2 diabetes, explore what it means to live with their condition and its associated comorbidities. Find out more.
Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint.
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
The cardiovascular, renal and metabolic systems are interconnected and dysfunction in one system may lead to dysfunction in the other. Learn more here.
COVID-19 Ivermectin Animal Health Not for Human Use
BI manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
A global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guidelines. Learn more.